Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$801K Buy
+4,367
New +$805K 0.01% 347
2023
Q4
Sell
-6,795
Closed -$1.75M 430
2023
Q3
$1.75M Buy
6,795
+1,031
+18% +$276K 0.04% 304
2023
Q2
$1.64M Sell
5,764
-2,618
-31% -$779K 0.04% 278
2023
Q1
$2.33M Buy
8,382
+1,359
+19% +$376K 0.06% 266
2022
Q4
$1.94M Buy
+7,023
New +$1.98M 0.06% 271

Other funds holding BIIB

LBP AM's BIIB Position: Q1 2026 in Review

LBP AM opened a new position in Biogen (BIIB) in Q1 2026: 4,367 shares worth $801K. The stake represents 0.01% of the portfolio and ranks #347 among its holdings. This is a return to the name: LBP AM previously reported a position in BIIB as recently as Q3 2023.

LBP AM first reported a position in BIIB in Q4 2022 and has held it in 5 quarters since. The position peaked at $2.33M in Q1 2023. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • LBP AM held 4,367 shares of Biogen worth $801K as of Q1 2026.
  • Biogen was a new LBP AM position in Q1 2026.
  • Biogen made up 0.01% of LBP AM's portfolio in Q1 2026, its #347 holding.
  • LBP AM first reported a position in Biogen in Q4 2022 and has held it in 5 quarters since.
  • LBP AM's Biogen position peaked at $2.33M in Q1 2023.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on LBP AM's 13F filing for Q1 2026, filed 27 Apr 2026.